222 related articles for article (PubMed ID: 24488262)
1. Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy.
Tang LQ; Liu S; Zhang ST; Zhu LN; Wang FL
Mol Biol Rep; 2014 May; 41(5):3339-47. PubMed ID: 24488262
[TBL] [Abstract][Full Text] [Related]
2. Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats.
Wang FL; Tang LQ; Yang F; Zhu LN; Cai M; Wei W
Mol Biol Rep; 2013 Mar; 40(3):2405-18. PubMed ID: 23196710
[TBL] [Abstract][Full Text] [Related]
3. The renoprotective effects of berberine via the EP4-Gαs-cAMP signaling pathway in different stages of diabetes in rats.
Yang Y; Ni W; Cai M; Tang L; Wei W
J Recept Signal Transduct Res; 2014 Dec; 34(6):445-55. PubMed ID: 24849498
[TBL] [Abstract][Full Text] [Related]
4. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
Zhu L; Han J; Yuan R; Xue L; Pang W
Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
[TBL] [Abstract][Full Text] [Related]
5. Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats.
Ni WJ; Tang LQ; Zhou H; Ding HH; Qiu YY
J Cell Mol Med; 2016 Aug; 20(8):1491-502. PubMed ID: 27098986
[TBL] [Abstract][Full Text] [Related]
6. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice.
Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M
Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805
[TBL] [Abstract][Full Text] [Related]
7. Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice.
Zhang X; He H; Liang D; Jiang Y; Liang W; Chi ZH; Ma J
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529235
[TBL] [Abstract][Full Text] [Related]
8. Berberine Acts on C/EBPβ/lncRNA Gas5/miR-18a-5p Loop to Decrease the Mitochondrial ROS Generation in HK-2 Cells.
Xu J; Liu L; Gan L; Hu Y; Xiang P; Xing Y; Zhu J; Ye S
Front Endocrinol (Lausanne); 2021; 12():675834. PubMed ID: 34526965
[TBL] [Abstract][Full Text] [Related]
9. [Regulatory effect of berberine on unbalanced expressions of renal tissue TGF-beta1/SnoN and smad signaling pathway in rats with early diabetic nephropathy].
Liu S; Yu N; Zhang XL; Chen XQ; Tang LQ
Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3604-10. PubMed ID: 23477149
[TBL] [Abstract][Full Text] [Related]
10. Exploring the molecular mechanism of berberine for treating diabetic nephropathy based on network pharmacology.
Yang L; Yuan S; Wang R; Guo X; Xie Y; Wei W; Tang L
Int Immunopharmacol; 2024 Jan; 126():111237. PubMed ID: 37977063
[TBL] [Abstract][Full Text] [Related]
11. Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy.
Tang LQ; Wang FL; Zhu LN; Lv F; Liu S; Zhang ST
Mol Biol Rep; 2013 Jun; 40(6):3913-23. PubMed ID: 23266672
[TBL] [Abstract][Full Text] [Related]
12. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
[TBL] [Abstract][Full Text] [Related]
13. Reduced IP receptors in STZ-induced diabetic rat kidneys and high-glucose-treated mesangial cells.
Nasrallah R; Hébert RL
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F673-81. PubMed ID: 15161601
[TBL] [Abstract][Full Text] [Related]
14. Berberine improves kidney function in diabetic mice via AMPK activation.
Zhao L; Sun LN; Nie HB; Wang XL; Guan GJ
PLoS One; 2014; 9(11):e113398. PubMed ID: 25409232
[TBL] [Abstract][Full Text] [Related]
15. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.
Noguchi K; Shitashige M; Endo H; Kondo H; Ishikawa I
J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936
[TBL] [Abstract][Full Text] [Related]
16. Berberine Improves the Protective Effects of Metformin on Diabetic Nephropathy in db/db Mice through Trib1-dependent Inhibiting Inflammation.
Zhang B; Zhang X; Zhang C; Sun G; Sun X
Pharm Res; 2021 Nov; 38(11):1807-1820. PubMed ID: 34773184
[TBL] [Abstract][Full Text] [Related]
17. Renoprotective effects of berberine and its potential effect on the expression of β-arrestins and intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in streptozocin-diabetic nephropathy rats.
Tang LQ; Ni WJ; Cai M; Ding HH; Liu S; Zhang ST
J Diabetes; 2016 Sep; 8(5):693-700. PubMed ID: 26531813
[TBL] [Abstract][Full Text] [Related]
18. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
[TBL] [Abstract][Full Text] [Related]
20. Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome.
Ma Z; Zhu L; Wang S; Guo X; Sun B; Wang Q; Chen L
Ren Fail; 2022 Dec; 44(1):923-932. PubMed ID: 35618411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
